register

News - Pharmaceuticals

New report reveals vast scope of work needed to optimally manage and treat osteoporosis

Health Industry Hub | October 20, 2021 |

Pharma News: Only one in two Australian adults who have broken a bone reported having a bone mineral density test (BMD) to investigate their bone health for the risk of fracture, and presence of osteoporosis. Even more concerningly, of those who have fractured a bone, the vast majority (86%) are not taking preventative osteoporosis medication.

These key findings among others from Healthy Bones Australia’s Know Your Bones Community Risk Report, Second Edition 2021, released today on World Osteoporosis Day, call for earlier investigation and treatment to capture all adults with risk factors for poor bone health, and adults post-fracture.

The new report summarises data from more than 88,000 Australians who have completed Know Your Bones to date – an online self-assessment tool developed by Healthy Bones Australia in partnership with the Garvan Institute of Medical Research, to help Australians understand their potential risk for developing osteoporosis, and bone breaks. The test provides the respondent with personalised recommendations about their bone health, which they can share with their GP for further discussion.

According to Healthy Bones Australia Medical Director and Senior Staff Specialist Rheumatologist at Westmead Hospital, Associate Professor Peter Wong, Sydney, specific risk factors increase a person’s risk for developing osteoporosis, including prior fracture, family history, certain medical conditions or medications, early menopause or low testosterone, lack of calcium or vitamin D, smoking, and high alcohol intake.

“Of the more than 88,000 Australians who have completed the Know Your Bones online self-assessment to date, nearly 40% reported having a clinical risk factor for osteoporosis, while the vast majority (99%) reported having at least one lifestyle risk factor.

“Given more than six million Australians over 50 years of age are living with poor bone health, we are encouraging adults to ‘Know Your Bones’, by completing our online self-assessment, to help curb the more than 183,000 fractures anticipated by 2022,” said A/Prof Wong.

Healthy Bones Australia Chair, Endocrinologist, and Head of the Department of Medicine, School of Clinical Sciences at Monash Health, Professor Peter Ebeling AO, Melbourne, says routine investigation of adults with risk factors for poor bone health is essential to secure an early osteoporosis diagnosis, protecting bone health, and preventing unnecessary fractures.

“Concerningly, our new report reveals one in three Know Your Bones respondents aged over 70 years have not had a BMD test, which is reimbursed by Medicare in this age group. This simple test measures bone density at the hip and spine to identify poor bone health,” Prof Ebeling said.

“Investigation rates of those with risk factors for poor bone health, or patients who have already broken a bone should be much higher, given this test is widely available and reimbursed. Early diagnosis of osteoporosis allows us to prevent unwanted fractures,” said Prof Ebeling.

In considering ground-breaking research and new therapies, Prof Ebeling told Health Industry Hub “I think the biggest recent change has been an increased number of treatments that build new bone. One called romosozumab has been available in Australia since April but its use is restricted to treatment failure in severe osteoporosis when ideally it should be used as a first line therapy in patients with the most severe osteoporosis.

The current delay in funding of innovative medicines in Australia is impacting patient outcomes and quality of life. The time to market between registration and reimbursement is lengthy at 391 days, the second slowest to market between registration and reimbursement in the world, longer than the OECD average. Prof Ebeling said to Health Industry Hub “I am grateful the PBAC ensures Australians have access to some of the lowest priced medicines in the world, however, these data clearly show the process is too slow. We need to stop believing ‘this is not a race’ and that begins from the top down.”

Consumer advocate, mother-to-three, and grandmother-to-twin girls, Elaine, 57, Melbourne, was finally diagnosed with severe osteoporosis in 2019 after enduring three years of excruciating back pain caused by unidentified spinal fractures. Elaine has an immediate family history of bone disease – her mum was diagnosed with osteoporosis at 70 years of age, while her sister has also experienced fractures.

“Despite my family history of bone disease, it never crossed my mind, nor was it even suggested to me, that I may be at risk for developing osteoporosis, even after going through menopause. Because I had never experienced any falls, no one suspected I was living with bone fractures. So I’m not actually sure how long I had been living with osteoporosis,” said Elaine.

Elaine maintains heightened public awareness of bone health is urgently required to help curb the prevention of painful but unnecessary fractures.

“I encourage everyone to use Know Your Bones and talk to your doctor about your bone health to prevent osteoporosis. The disease has substantially impacted my life, and I want others to avoid the pain I have gone through.”

“Know Your Bones represents a simple first step for Australians to consider their bone health, and can be performed in the comfort of their own homes,” said CEO of Healthy Bones Australia, Greg Lyubomirsky, Sydney.

“Fractures place a huge burden on the cost of the healthcare system and account for the majority (69%) of the expected AUD 3.85 billion, in 2022, including emergency costs, hospital stays, rehabilitation, and community services. We need to educate the community about the risk factors for poor bone health, and ensure adults with risk factors are investigated as part of a routine medical check-up.”


News - MedTech & Diagnostics

Roche unlocks new horizons for genomic research in Asia Pacific

Roche unlocks new horizons for genomic research in Asia Pacific

Health Industry Hub | November 9, 2026 |

Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]

More


News - Pharmaceuticals

'Unexpected and Surprising': Novartis’ Lp(a) setback raises tough questions for Amgen and Lilly - Professor Stephen Nicholls, Victorian Heart Hospital

‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly

Health Industry Hub | November 9, 2026 |

The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]

More


News - MedTech & Diagnostics

More public hospitals turn to same-day hip and knee surgery but recovery risks persist

More public hospitals turn to same-day hip and knee surgery, but key blind spots persist

Health Industry Hub | November 9, 2026 |

Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]

More


News - Pharmaceuticals

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

Health Industry Hub | November 9, 2026 |

The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]

More


This content is copyright protected. Please subscribe to gain access.